State-of-the-art assays and early warning biosensors of weaponized pathogens that are highly multiplexed, integrated and field deployable will be introduced. For biodefense applications, these need to require minimal sample prep, should be compact and be able to identify and analyze strains and show reliable results in minutes. Multi-use application is an essential feature to develop products that will also have utility in healthcare. It is imperative that the infrastructure be developed that includes a decision-making hierarchy in the event of a bioterrorism outbreak. A discussion on getting products to market will cover how technology transitions from a research setting to a real world setting, and will tackle pragmatic issues of implementation. In addition, novel vaccines and antidotes for biodefense applications will be showcased. This year, the meeting will be paired with a new meeting called Enabling Point-of-Care Diagnostics, which will expand coverage of devices for dual-use biodefense and clinical applications.

Sessions Include:  

• Implementing Technologies in Real World Settings

• Protective Countermeasures

• Advancements in Rapid Biodefense Countermeasures

• Medical Countermeasures: From Mechanism Of Action To A Next Generation Vaccine 

• Bridging Biodefense and Clinical Applications